Task A92: Efficacy of Antiviral Therapeutics Against MERS-CoV in a Mouse-Adapted Virus Model
$637,479N01FY2024AINIH
Univ Of North Carolina Chapel Hill, Chapel Hill NC
Investigators
Abstract
This contract provides for the development of new and refinement of existing models of infectious diseases and may include evaluation of candidate countermeasures.
View original record on NIH RePORTER →